Feedback / Questions
scopolamine intranasal (DPI-386) - Defender Pharma
https://www.globenewswire.com/news-release/2023/06/05/2682084/0/en/Defender-Pharmaceuticals-Reports-Positive-Results-from-Pivotal-Phase-III-Clinical-Trial-of-Intranasal-Scopolamine-for-the-Prevention-of-Nausea-and-Vomiting-Induced-by-Motion.html
Jun 5, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next